Recruiting

MyVitalC

Sponsor:

Efforia, Inc

Code:

NCT07477236

Conditions

Sleep

Headaches

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Interventions

MyVitalC (ESS60 in Extra Virgin Olive Oil)

Study Details

Brief summary:

Sleep disturbance and recurring headaches can negatively affect daily functioning, mood, and productivity. MyVitalC (ESS60 in extra virgin olive oil) is a commercially available dietary supplement that has generated anecdotal claims related to sleep quality and headache relief; however, human data remain limited.

This real-world observational study is designed to help participants evaluate whether use of MyVitalC is associated with changes in sleep disturbance and headache frequency or severity in their own daily lives. Participants will complete a four-week baseline observation period without the intervention, followed by six weeks of daily MyVitalC use, with weekly self-reported assessments. Participants serve as their own control, allowing for within-person comparison of outcomes before and during product use.

Conditions

Sleep

Headaches

Study ID

NCT07477236

Start date

Jan 24, 2026

Status verified date

Jan, 2026

Completion date

Jan 24, 2027

Anticipated

Primary completion date

Jan 24, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Adults of legal age of consent
  • Able to provide informed consent
  • Willing to complete weekly assessments and daily logs
  • Able to purchase and use the study product

Exclusion Criteria:

  • Have known allergies to olive oil or product components
  • Are pregnant or breastfeeding
  • Have severe or chronic headache disorders
  • Have significant gastrointestinal conditions
  • Have medical conditions that could be exacerbated by supplement use
  • Have concerns about dizziness, fatigue, or mood disturbances
  • Are subject to organizational or legal restrictions on supplement use

Study Design

Enrollment

100 participants

Anticipated

Intervention Model

Single group

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Single Arm longitudinal where participants act as their own control

Single Arm longitudinal where participants act as their own control

Interventions

MyVitalC (ESS60 in Extra Virgin Olive Oil)

Participants will take 1 teaspoon (5 mL) of MyVitalC, ESS60 in extra virgin olive oil, orally once daily in the morning, with or without food, for six weeks. Daily intake is logged within the study platform.

Primary outcome measure

  • Change in Sleep Disturbance [ Time Frame: Weekly during baseline (4 weeks) and weekly during intervention (6 weeks) ]
  • Change in Headache Frequency [ Time Frame: Weekly during baseline and intervention, and on day 70 (end of study) ]
  • Change in Headache Severity [ Time Frame: Weekly during baseline and intervention, and on day 70 (end of study) ]

Central Contacts and Locations

Central contacts

Matthew Amsden

(646) 679-2479help@efforia.com

Locations

Efforia

Recruiting

New York, New York, United States, 10003

Contacts

Matthew Amsden

(646) 679-2479help@efforia.com

More Information

Sponsor

Efforia, Inc

Last update posted

Mar 17, 2026

Last verified

Jan, 2026

Keywords

  • Sleep
  • Headaches

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Efforia, Inc on 2026-03-17.